4.5 Review

Structural Insights into Phospholipase C-β Function

期刊

MOLECULAR PHARMACOLOGY
卷 84, 期 4, 页码 488-500

出版社

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.113.087403

关键词

-

资金

  1. American Heart Association [11POST7620083]
  2. National Institutes of Health National Heart, Lung, and Blood Institute [R01 HL086865, R01 HL071818]
  3. National Institutes of Health National Institute of General Medical Sciences [GM081655]

向作者/读者索取更多资源

Phospholipase C (PLC) enzymes convert phosphatidylinositol-4,5-bisphosphate into the second messengers diacylglycerol and inositol-1,4,5-triphosphate. The production of these molecules promotes the release of intracellular calcium and activation of protein kinase C, which results in profound cellular changes. The PLC beta subfamily is of particular interest given its prominent role in cardiovascular and neuronal signaling and its regulation by G protein-coupled receptors, as PLC beta is the canonical downstream target of the heterotrimeric G protein G alpha q. However, this is not the only mechanism regulating PLC beta activity. Extensive structural and biochemical evidence has revealed regulatory roles for autoinhibitory elements within PLC beta, G beta gamma, small molecular weight G proteins, and the lipid membrane itself. Such complex regulation highlights the central role that this enzyme plays in cell signaling. A better understanding of the molecular mechanisms underlying the control of its activity will greatly facilitate the search for selective small molecule modulators of PLC beta.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据